Women between the ages of 40 and 49 years who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors than symptomatic women requiring diagnostic workup, according to a study published in the May issue of
American Journal of Roentgenology.
The most common treatment for ductal carcinoma in situ (DCIS) is breast-conserving surgery (BCS) and while the procedure has been shown to be effective at reducing cancer mortality, women undergoing BCS should be prepared for the possibility of future diagnostic mammograms and invasive breast procedures for as long as 10 years after surgery, according to research published online April 5 in the Journal of the National Cancer Institute.
Using computer-aided detection (CAD) software to help analyze and interpret mammograms does not improve accuracy, but it does raise a woman’s risk of being recalled for additional testing, according to a study published online July 27 in the
Journal of the National Cancer Institute. An accompanying editorial suggested the need for further improvements in CAD software and described existing technology as “more harmful than beneficial.”
As many as one-fourth of cases of ductal carcinoma in situ (DCIS) diagnosed using core-needle biopsy are in fact understaged invasive breast cancers, according to a study published in the July issue of
Radiology.
